合成磁共振成像方法MAGiC预测乳腺癌患者新辅助化疗疗效:一项观察性队列研究
前瞻性队列纳入2021-2023年接受新辅助化疗的120例乳腺癌患者,按Miller-Payne分级分为部分病理缓解组(73例,60.83%)和病理完全缓解组(47例,39.17%)。部分病理缓解组T2值显著低于病理完全缓解组,T1和PD值无显著差异;T2预测部分病理缓解的AUC为0.780,淋巴结转移和低T2水平为部分病理缓解的独立危险因素。
要点
- 部分病理缓解组T2值显著低于病理完全缓解组,T1和PD值无显著差异。
- T2值预测部分病理缓解的AUC为0.780。
- 淋巴结转移和低T2水平是部分病理缓解的独立危险因素。
核心结论
- MAGiC的T2值参数是乳腺癌患者新辅助化疗后部分病理缓解的独立危险因素,提示其可能作为预测治疗疗效的生物标志物。
研究设计与样本
- 前瞻性观察性队列研究,纳入2021-2023年接受新辅助化疗的120例乳腺癌患者,采用MAGiC合成磁共振成像测量纵向T1、T2和PD值,以Miller-Payne分级为参考标准分为部分病理缓解组和病理完全缓解组。
关键影像表现/征象
- 部分病理缓解组T2值显著低于病理完全缓解组。
- T1和PD值在部分病理缓解组与病理完全缓解组间无显著差异。
- MAGiC各参数与HER-2、ER或PR均无显著相关性。
诊断标准与关键数值
- T2值预测部分病理缓解的AUC为0.780。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: MAGnetic resonance Imaging Compilation (MAGiC) is typical method of synthetic magnetic resonance imaging (MRI). The present aimed to investigate the role of MAGiC parameters of relaxation time (T1), transverse relaxation time (T2) and proton density (PD) to predict the treatment efficacy of breast cancer patients after neoadjuvant chemotherapy (NAC).
METHODS: The present prospective cohort study enrolled 120 breast cancer patients who received NAC during 2021-2023. Demographic data and clinical characteristics including tumor node metastasis (TNM) stage, pathological type, molecular classification and lymph node metastasis were collected. The levels of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER-2) were measured. Patients were divided by treatment efficacy using the Miller-Payne grading as partial pathological response (pPR) group and pathological complete response (pCR). The values of MAGiC parameters of longitudinal T1, T2, and PD values were recorded.
RESULTS: In all 120 patients, 73 (60.83%) cases were with pPR and 47 (39.17%) cases were with pCR after treatment. T2 values were markedly lower in pPR patients compared with pCR patients. However, no significant difference was found for T1 and PD values. No significant correlation was observed between any of MAGiC parameters and HER-2, ER or PR. ROC curve showed T2 could be used for prediction of pPR with AUC 0.780. Lymph node metastasis and low levels of T2 were found as independent risk factors for pPR after treatment.
CONCLUSION: The T2 value parameter from MAGiC is an independent risk factor for pPR following NAC in breast cancer patients, suggesting its potential as a biomarker for predicting treatment efficacy.
引用
- Zhan T, Yi C, Lang Y, et al. Predicting efficacy of neoadjuvant chemotherapy in breast cancer patients with synthetic magnetic resonance imaging method MAGiC: An observational cohort study. Eur J Radiol. 2024. PMID: 39128250. doi:10.1016/j.ejrad.2024.111666
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。